https://www.selleckchem.com/pr....oducts/msdc-0160.htm
ble clinical results. Level IV (case series). Retrospective study. Level IV (case series). Retrospective study. Custom genes have become a common resource in recombinant biology over the last 20 years due to the plummeting cost of DNA synthesis. These genes are often "optimized" to non-native sequences for overexpression in a non-native host by substituting synonymous codons within the coding DNA sequence (CDS). A handful of studies have compared native and optimized CDSs, reporting different levels of soluble product due to the accum
Мне нравится
Комментарий
Перепост
